Affiliation:
1. School of Pharmacy, The Key Laboratory of Prescription Effect and Clinical Evaluation of State Administration of Traditional Chinese Medicine of China, Binzhou Medical University , Yantai , 264003 , P. R. China
2. Shandong Institute of Standardization , Jinan , 250014 , P. R. China
Abstract
Abstract
C18H15BrO2, monoclinic, P21/n (no. 14), a = 9.1704(9) Å, b = 16.5309(13) Å, c = 10.3528(12) Å, β = 112.368(12)°, V = 1451.3(3) Å3, Z = 4, R
gt
(F) = 0.0405, wR
ref
(F
2) = 0.0677, T = 149.99(10) K.
Funder
Shandong Provincial Natural Science Foundation
College Youth Innovation Science and Technology Support Programme of Shandong Province
Key R&D Programme of Shandong Province
Shandong New Drug Loading & Release Technology and Preparation Engineering Laboratory
Subject
Inorganic Chemistry,Condensed Matter Physics,General Materials Science
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Crystal structure of (E)-6-(4-ethylpiperazin-1-yl)-2-(3-fluorobenzylidene)-3,4-dihydronaphthalen-1(2H)-one, C23H25FN2O;Zeitschrift für Kristallographie - New Crystal Structures;2024-04-03
2. Crystal structure of 9-fluoro-4-(6-methoxypyridin-3-yl)-5,6-dihydrobenzo[h]quinazolin-2-amine, C18H15FN4O;Zeitschrift für Kristallographie - New Crystal Structures;2023-11-07
3. Crystal structure of 2-((2-fluoro-4-(trifluoromethyl)phenyl)(hydroxy)methyl)-7-methoxy-3,4-dihydronaphthalen-1((2H))-one, C19H16F4O3;Zeitschrift für Kristallographie - New Crystal Structures;2023-10-10
4. Crystal structure of (E)-7-fluoro-2-(4-morpholinobenzylidene)-3,4-dihydronaphthalen-1(2H)-one, C21H20FNO2;Zeitschrift für Kristallographie - New Crystal Structures;2023-03-14
5. Crystal structure of (E)-7-methoxy-2-(4-morpholinobenzylidene)-3,4-dihydronaphthalen-1(2H)-one, C22H23NO3;Zeitschrift für Kristallographie - New Crystal Structures;2023-02-14